Abstract
NOS2 and COX2 predicts poor outcome in ER- breast cancer through immunosuppression. Novel Strategies to overcome immunosuppression
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/j.canlet.2023.216537
Journal: Cancer Letters | Publication Date: Dec 10, 2023 |
NOS2 and COX2 predicts poor outcome in ER- breast cancer through immunosuppression. Novel Strategies to overcome immunosuppression
Join us for a 30 min session where you can share your feedback and ask us any queries you have